- Home
- GNTX vs PCVX Comparison
GNTX vs PCVX Comparison
Compare GNTX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTX | PCVX |
|---|---|---|
| Founded | 1974 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 6.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GNTX | PCVX |
|---|---|---|
| Price | $22.95 | $49.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $29.00 | ★ $101.67 |
| AVG Volume (30 Days) | ★ 2.4M | 1.4M |
| Earning Date | 10-24-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $2,431,504,922.00 | N/A |
| Revenue This Year | $11.92 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | $13.44 | ★ N/A |
| Revenue Growth | ★ 3.00 | N/A |
| 52 Week Low | $20.28 | $27.66 |
| 52 Week High | $31.25 | $94.76 |
Technical Indicators
Market Signals| Indicator | GNTX | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 65.33 |
| Support Level | $21.69 | $47.02 |
| Resistance Level | $22.54 | $50.27 |
| Average True Range (ATR) | 0.44 | 2.03 |
| MACD | 0.15 | 0.15 |
| Stochastic Oscillator | 60.90 | 93.32 |
Price Performance
Historical ComparisonAbout GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.